HIT Health In Tech, Inc. - Class A Common Stock
$0.98
Price · May 20, 2026
Fundamentals as of May 14, 2026
52W Range
$1–$4
12% of range
Analyst Rating
BUY
5 analysts
Price Target
$4
+327% upside
P/E (TTM)
79.5
ROE
7.6%
Net Profit Margin
3.8%
HIT Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
Price
$0.98
Market Cap
—
P/E (TTM)
79.5
EPS (TTM)
$0.02
Revenue (TTM)
$33M
Div Yield
—
ROE
7.6%
Debt/Equity
—
52W Range
$1 – $4
HIT Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
Configure
10-Year Performance Revenue, net income, margins and EPS trends
Revenue & Net Income
$33M
2023-12-31
→
2025-12-31
EPS
$0.02
2024-12-31
→
2025-12-31
Free Cash Flow
—
Margins
3.8%
2024-12-31
→
2025-12-31
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
Metric
5Y trend
HIT
Peer Median
P/E (TTM)
79.5
21.3
Profitability Gross, operating and net margins; ROE, ROA, ROIC
Metric
5Y trend
HIT
Peer Median
Gross Margin
62.8%
73.4%
Net Profit Margin
3.8%
6.0%
ROA
6.6%
4.9%
ROE
7.6%
8.2%
Financial Health Debt, liquidity, solvency — balance sheet strength
Metric
5Y trend
HIT
Peer Median
Current Ratio
3.1
1.9
Quick Ratio
1.6
—
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
Metric
5Y trend
HIT
Peer Median
Revenue YoY
71.0%
—
EPS YoY
100.0%
—
Net Income YoY
90.7%
—
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
Metric
5Y trend
HIT
Peer Median
HIT Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
BUY
5 analysts
- Strong Buy 1 20.0%
- Buy 3 60.0%
- Hold 1 20.0%
- Sell 0 0.0%
- Strong Sell 0 0.0%
12-Month Price Target
3 analysts · 2026-05-16
Median
$4.00
Mean
$4.18
← Below all targets
$0.98
Low
$4.00
High
$4.55
Median target
$4.00
+308.2%
Mean target
$4.18
+326.9%
Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
Avg Surprise
0.00%
| Period | EPS Actual | EPS Est | Surprise |
|---|---|---|---|
| March 31, 2026 | $-0.03 | $-0.03 | 0.00% |
| Dec. 31, 2025 | $0.00 | $-0.01 | 0.01% |
| Sept. 30, 2025 | $0.01 | $0.01 | -0.00% |
| June 30, 2025 | $0.01 | $0.01 | -0.00% |
| March 31, 2025 | $0.01 | $0.02 | -0.01% |
Peer Comparison Key metrics vs sector peers
| Ticker | Market Cap | P/E | Rev YoY | Net Margin | ROE | Gross Margin |
|---|---|---|---|---|---|---|
| HIT | — | 79.5 | 71.0% | 3.8% | 7.6% | 62.8% |
| LIFE | — | — | 52.0% | 18.4% | -108.4% | — |
| TWFG | — | 54.3 | 22.0% | — | — | — |
| ABX | $833M | 23.8 | 110.2% | 15.5% | 8.8% | 87.7% |
| SLQT | $411M | 238.0 | 15.5% | 3.1% | 14.1% | — |
| EHTH | $143M | -13.5 | 4.1% | 7.2% | 7.0% | 43.5% |
| GOCO | — | -0.1 | -54.7% | -71.1% | -183.8% | — |
| EZRA | — | -0.4 | -11.6% | — | — | — |
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Income Statement 16
| Metric | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Revenue | $33M | $19M | $19M | |
| Cost of Revenue | $12M | $4M | $2M | |
| Gross Profit | $21M | $15M | $17M | |
| R&D Expense | $2M | $3M | $2M | |
| SG&A Expense | $14M | $8M | $8M | |
| Operating Expenses | $19M | $14M | $13M | |
| Interest Income | $409.9K | $122.9K | $40.9K | |
| Other Non-op | $145.7K | $-100.9K | $38.8K | |
| Pretax Income | $2M | $889.0K | $3M | |
| Income Tax | $395.3K | $218.5K | $945.2K | |
| Net Income | $1M | $670.5K | $4M | |
| EPS (Basic) | $0.02 | $0.01 | · | |
| EPS (Diluted) | $0.02 | $0.01 | · | |
| Shares (Basic) | 55,843,821 | 51,839,329 | · | |
| Shares (Diluted) | 57,742,798 | 53,662,677 | · | |
| EBITDA | $900.6K | · | · |
Balance Sheet 15
| Metric | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Cash & Equivalents | $8M | $8M | $2M | |
| Receivables | $756.3K | $2M | $2M | |
| Prepaid Expense | $3M | $787.2K | $264.4K | |
| Current Assets | $16M | $11M | $7M | |
| Total Assets | $23M | $16M | $12M | |
| Accounts Payable | $4M | $2M | $3M | |
| Short-term Debt | · | · | $2M | |
| Current Liabilities | $5M | $2M | $5M | |
| Capital Leases | $63.6K | $139.8K | $206.7K | |
| Deferred Tax | $757.7K | $328.7K | $422.0K | |
| Total Liabilities | $6M | $3M | $5M | |
| Paid-in Capital | · | $9M | $3M | |
| Retained Earnings | $5M | $4M | $3M | |
| Stockholders' Equity | $17M | $13M | $6M | |
| Liabilities + Equity | $23M | $16M | $12M |
Cash Flow 10
| Metric | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| D&A | $900.6K | $541.1K | $339.3K | |
| Stock-based Comp | $2M | $468.5K | · | |
| Deferred Tax | $429.0K | $-93.3K | $134.0K | |
| Other Non-cash | $-1M | · | · | |
| Operating Cash Flow | $3M | $2M | $2M | |
| Investing Cash Flow | $-3M | $-836.8K | $-2M | |
| Stock Issued | · | $8M | · | |
| Net Stock Activity | · | $8M | · | |
| Financing Cash Flow | $-187.4K | $4M | $1M | |
| Taxes Paid | $830.7K | $558.5K | $479.2K |
Profitability 6
| Metric | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Gross Margin | 62.8% | 79.2% | · | |
| Net Margin | 3.8% | 3.4% | · | |
| Pretax Margin | 5.0% | 4.6% | · | |
| EBITDA Margin | 2.7% | · | · | |
| ROA | 6.6% | 4.9% | · | |
| ROE | 7.6% | 6.7% | · |
Liquidity & Solvency 2
| Metric | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Current Ratio | 3.1 | 5.1 | · | |
| Quick Ratio | 1.6 | 4.5 | · |
Efficiency 2
| Metric | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Asset Turnover | 1.7 | 1.4 | · | |
| Receivables Turnover | 27.7 | 10.0 | · |
Growth Rates 3
| Metric | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Revenue YoY | 71.0% | 1.8% | · | |
| EPS YoY | 100.0% | · | · | |
| Net Income YoY | 90.7% | -83.1% | · |
Valuation (TTM) 4
| Metric | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Revenue TTM | $33M | $19M | · | |
| Net Income TTM | $1M | $670.5K | · | |
| P/E | 79.5 | 535.5 | · | |
| Earnings Yield | 1.3% | 0.19% | · |
Income Statement 16
| Metric | Trend | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $9M | $8M | $8M | $9M | $8M | $5M | $4M | $5M | $5M | |
| Cost of Revenue | $4M | $3M | $3M | $3M | $3M | $1M | $979.6K | $974.7K | $989.9K | |
| Gross Profit | $5M | $4M | $5M | $6M | $5M | $4M | $3M | $4M | $4M | |
| R&D Expense | $920.4K | $213.1K | $235.8K | $582.6K | $537.7K | $633.7K | $718.4K | $701.6K | $760.2K | |
| SG&A Expense | $3M | $3M | $3M | $4M | $3M | $3M | $2M | $2M | $2M | |
| Operating Expenses | $7M | $4M | $5M | $6M | $5M | $4M | $3M | $3M | $4M | |
| Interest Income | $67.5K | $104.7K | $111.7K | $108.2K | $85.4K | $28.8K | $38.5K | $31.3K | $24.3K | |
| Other Non-op | $89.8K | $-272.9K | $106.7K | $108.2K | $203.8K | $205.6K | $-32.1K | $-133.7K | $-140.7K | |
| Pretax Income | $-2M | $-443.7K | $600.2K | $833.3K | $684.4K | $-110.7K | $406.7K | $401.3K | $191.7K | |
| Income Tax | $-480.1K | $-141.2K | $148.0K | $202.6K | $185.8K | $33.4K | $30.7K | $63.3K | $91.2K | |
| Net Income | $-2M | $-302.6K | $452.2K | $630.6K | $498.6K | $-144.2K | $376.1K | $338.0K | $100.5K | |
| EPS (Basic) | $-0.03 | $-0.01 | $0.01 | $0.01 | $0.01 | $-0.01 | $0.01 | $0.01 | · | |
| EPS (Diluted) | $-0.03 | $-0.01 | $0.01 | $0.01 | $0.01 | $-0.01 | $0.01 | $0.01 | · | |
| Shares (Basic) | 57,353,021 | -110,590,839 | 56,432,407 | 55,382,395 | 54,619,858 | -103,468,745 | 51,769,358 | 51,769,358 | 51,769,358 | |
| Shares (Diluted) | 57,353,021 | -113,660,829 | 58,774,334 | 55,632,357 | 56,996,936 | -101,645,397 | 51,769,358 | 51,769,358 | 51,769,358 | |
| EBITDA | $403.5K | · | · | · | $136.0K | · | · | · | · |
Balance Sheet 13
| Metric | Trend | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $10M | $8M | $8M | $8M | $8M | $8M | · | · | · | |
| Receivables | $4M | $756.3K | $868.6K | $1M | $2M | $2M | · | · | · | |
| Prepaid Expense | $3M | $3M | $2M | $2M | $2M | $787.2K | · | · | · | |
| Current Assets | $22M | $16M | $15M | $15M | $16M | $11M | · | · | · | |
| Total Assets | $29M | $23M | $23M | $22M | $21M | $16M | · | · | · | |
| Accounts Payable | $7M | $4M | $4M | $4M | $5M | $2M | · | · | · | |
| Current Liabilities | $7M | $5M | $5M | $5M | $7M | $2M | · | · | · | |
| Capital Leases | $42.9K | $63.6K | $83.8K | $102.9K | $121.6K | $139.8K | · | · | · | |
| Deferred Tax | $273.2K | $757.7K | $274.8K | $262.1K | $294.2K | $328.7K | · | · | · | |
| Total Liabilities | $7M | $6M | $6M | $6M | $7M | $3M | · | · | · | |
| Retained Earnings | $4M | $5M | $6M | $5M | $4M | $4M | · | · | · | |
| Stockholders' Equity | $22M | $17M | $17M | $16M | $14M | $13M | · | · | · | |
| Liabilities + Equity | $29M | $23M | $23M | $22M | $21M | $16M | · | · | · |
Cash Flow 10
| Metric | Trend | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $403.5K | $410.6K | $218.0K | $136.0K | $136.0K | $136.0K | $135.6K | $134.8K | $134.8K | |
| Stock-based Comp | $366.6K | $76.7K | $292.6K | $708.0K | $493.2K | · | · | · | · | |
| Deferred Tax | $-484.5K | $482.9K | $12.7K | $-32.1K | $-34.5K | $-6.3K | $-27.7K | $754 | $-60.1K | |
| Other Non-cash | $-2M | · | · | · | $-565.9K | · | · | · | · | |
| Operating Cash Flow | $-3M | $451.2K | $674.0K | $1M | $527.4K | $-531.2K | $2M | $1M | $-680.2K | |
| Investing Cash Flow | $-362.1K | $-767.7K | $-744.8K | $-909.9K | $-703.5K | $-542.1K | $-67.3K | $-94.0K | $-133.4K | |
| Stock Issued | $6M | · | $0 | $0 | · | · | · | · | · | |
| Net Stock Activity | $6M | · | · | · | $8M | · | · | · | · | |
| Financing Cash Flow | $6M | $-37.4K | $-43.7K | $-8.2K | $-98.1K | $7M | $-2M | $-368.9K | $-243.2K | |
| Taxes Paid | $5.0K | $7.4K | $198.0K | · | · | $217.7K | $15.3K | $286.3K | $39.2K |
Profitability 6
| Metric | Trend | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 51.4% | · | 60.6% | 67.8% | 66.8% | · | · | · | · | |
| Net Margin | -18.1% | · | 5.3% | 6.8% | 6.2% | · | · | · | · | |
| Pretax Margin | -23.6% | · | 7.1% | 8.9% | 8.5% | · | · | · | · | |
| EBITDA Margin | 4.6% | · | · | · | 1.7% | · | · | · | · | |
| ROA | -6.3% | · | 4.0% | 5.7% | 4.7% | · | · | · | · | |
| ROE | -8.9% | · | 5.3% | 7.7% | 7.0% | · | · | · | · |
Liquidity & Solvency 2
| Metric | Trend | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.1 | · | 2.9 | 2.8 | 2.3 | · | · | · | · | |
| Quick Ratio | 2.0 | · | 1.7 | 1.7 | 1.4 | · | · | · | · |
Efficiency 2
| Metric | Trend | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.3 | · | 0.7 | 0.8 | 0.8 | · | · | · | · | |
| Receivables Turnover | 3.0 | · | 19.5 | 14.5 | 7.6 | · | · | · | · |
Valuation (TTM) 4
| Metric | Trend | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $35M | · | $30M | $27M | $23M | · | · | · | · | |
| Net Income TTM | $-6.9K | · | $2M | $2M | $1M | · | · | · | · | |
| P/E | · | · | 80.2 | 22.0 | · | · | · | · | · | |
| Earnings Yield | 0.00% | · | 1.2% | 4.5% | · | · | · | · | · |
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
Income Statement
| 2025-12-31 | 2024-12-31 | 2023-12-31 | |
|---|---|---|---|
| Revenue | $33M | $19M | $19M |
| Gross Margin % | 62.8% | 79.2% | — |
| Net Income | $1M | $670.5K | $4M |
| Diluted EPS | $0.02 | $0.01 | — |
Balance Sheet
| 2025-12-31 | 2024-12-31 | 2023-12-31 | |
|---|---|---|---|
| Current Ratio | 3.1 | 5.1 | — |
| Quick Ratio | 1.6 | 4.5 | — |
My Metrics Your personal watchlist — selected rows from Full Fundamentals
📊
Pick the metrics that matter to you — click the ➕ next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.